Dr. John M. Schallenkamp
Claim this profileBenefis Healthcare- Sletten Cancer Institute
Expert in Cancer
Expert in Lung Cancer
177 reported clinical trials
254 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials John M. Schallenkamp is currently running
Surgery and Radiation vs. Radiation Alone
for Brain Cancer
This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.
Recruiting2 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
More about John M. Schallenkamp
Clinical Trial Related4 years of experience running clinical trials · Led 177 trials as a Principal Investigator · 104 Active Clinical TrialsTreatments John M. Schallenkamp has experience with
- Nivolumab
- Carboplatin
- Pembrolizumab
- Cisplatin
- Paclitaxel
- Radiation Therapy
Breakdown of trials John M. Schallenkamp has run
Cancer
Lung Cancer
Breast Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John M. Schallenkamp specialize in?
John M. Schallenkamp focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is John M. Schallenkamp currently recruiting for clinical trials?
Yes, John M. Schallenkamp is currently recruiting for 102 clinical trials in Great Falls Montana. If you're interested in participating, you should apply.
Are there any treatments that John M. Schallenkamp has studied deeply?
Yes, John M. Schallenkamp has studied treatments such as Nivolumab, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with John M. Schallenkamp?
Apply for one of the trials that John M. Schallenkamp is conducting.
What is the office address of John M. Schallenkamp?
The office of John M. Schallenkamp is located at: Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana 59405 United States. This is the address for their practice at the Benefis Healthcare- Sletten Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.